or Try an Advanced Search...

    Technical Analysis for SKYE - Skye Bioscience, Inc.

    Grade Last Price % Change Price Change
    D 12.50 -1.81% -0.23
    SKYE closed down 1.81 percent on Wednesday, May 8, 2024, on 53 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical SKYE trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish -1.81%
    Narrow Range Bar Range Contraction -1.81%
    Wide Bands Range Expansion -1.81%
    Older End-of-Day Signals for SKYE ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 12 hours ago
    Down 2 % about 17 hours ago
    Gap Up Closed about 17 hours ago
    60 Minute Opening Range Breakdown about 17 hours ago
    Down 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SKYE Chart by TradingView
    Basic chart:

    Profile

    Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Disease Drug Design

    Is SKYE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 30 Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
    Apr 23 Skye Bioscience to Present at Upcoming Investment Conferences
    Apr 10 Skye Bioscience to uplist to Nasdaq Global Market
    Apr 10 Skye Bioscience Uplists to The Nasdaq Global Market
    See more SKYE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.4099
    52 Week Low 0.0074
    Average Volume 54,612
    200-Day Moving Average 4.80
    50-Day Moving Average 13.48
    20-Day Moving Average 13.79
    10-Day Moving Average 12.87
    Average True Range 1.24
    RSI (14) 39.39
    ADX 14.22
    +DI 31.66
    -DI 24.82
    Chandelier Exit (Long, 3 ATRs) 13.93
    Chandelier Exit (Short, 3 ATRs) 11.97
    Upper Bollinger Bands 16.87
    Lower Bollinger Band 10.71
    Percent B (%b) 0.29
    BandWidth 44.65
    MACD Line -0.02
    MACD Signal Line 0.20
    MACD Histogram -0.2237
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 14.26
    Resistance 3 (R3) 14.39 13.94 13.96
    Resistance 2 (R2) 13.94 13.49 13.87 13.86
    Resistance 1 (R1) 13.22 13.22 13.00 13.09 13.77
    Pivot Point 12.77 12.77 12.66 12.70 12.77
    Support 1 (S1) 12.05 12.32 11.83 11.92 11.23
    Support 2 (S2) 11.60 12.05 11.53 11.14
    Support 3 (S3) 10.88 11.60 11.04
    Support 4 (S4) 10.75